Kinetoplastid SL RNA Biogenesis
Kinetoplastid SL RNA Biogenesis
批准号:
8507127
负责人:
DAVID A CAMPBELL
金额:
$35.01万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2015-06-30
关键词:
AddressAfrican TrypanosomiasisBindingBiogenesisBiologyBlood CirculationCatalytic DomainCell LineCell NucleolusCell NucleusChagas DiseaseClinicalCodeComplementComplexCore ProteinDiseaseEnzymesExonsExonucleaseFamilyFamily memberGene ExpressionGenesGeneticGenetic TranscriptionGenomeGoalsHealthHomologous GeneHumanHypermethylationIn VitroIndividualInsect VectorsInterventionKinetoplastidaKnock-outLeishmaniaLeishmaniasisLifeLinkMedicalMessenger RNAMethylationMethyltransferaseMitochondrial RNAModificationMolecularNamesNuclearNucleotidesOrganismParasitesPathway interactionsPlayPolishesPositioning AttributeProcessPropertyProtein SplicingProteinsProtozoaPseudouridineRNA ProcessingRNA SplicingReactionResearchRibonucleoproteinsRiboseRibosomal RNARoleRouteSmall Nuclear RNASmall RNASpliced Leader RNASpliced Leader SequencesStagingTechnologyTestingTherapeuticTrans-SplicingTransfer RNATranslationsTrypanosoma brucei bruceiTrypanosomatinaUridineValidationWorkchemotherapycombatfight againstgenome databasein vivoinsertion/deletion mutationinsightinterestnovelparticlepathogenprotein complexprotein purificationresearch studyrole modelspleen exonucleasetherapeutic targettraffickingvector
中文摘要
描述(由申请人提供):我们的研究旨在了解锥虫科的基因表达,该科包括导致利什曼病、非洲昏睡病和恰加斯病的寄生原虫。剪接先导RNA (slrna)是一种小RNA,通过反式剪接反应为每个核信使RNA提供5'端序列,并且在整个目中在初级序列水平上非常保守。反式剪接是将多顺反子前信使RNA转化为单顺反子信使RNA所必需的,这可能是在着丝质体中发现的不寻常的基因组组织的结果,并且在人类宿主或昆虫载体中没有发现,因此代表了理想的治疗靶点。本提案概述了在单个蛋白和相互作用复合物水平上详细描述了利什曼原虫和布鲁氏锥虫共有的SL RNA成熟途径的实验,并探讨了SL在翻译中的作用。1)我们将探索cap 4 2'- o -核糖甲基转移酶在布鲁氏菌血流形态中的作用,并利用敲除菌株验证其在前环布鲁氏菌中的功能。我们将研究TbMTr1的帽结合特性,并测试TbMTAP和TbMTr1在核内运输和与假尿嘧啶合成酶复合物相互作用中的作用模型。2)进一步研究参与SL RNA生物发生和功能的复合物。PTP标记、多维蛋白鉴定技术(MudPIT)和布氏体基因组数据库的三位一体使我们能够接近复杂的纯化。着丝质体特异性TbMTr1复合体蛋白TbMTAP参与调控和结构相互作用。利用SmD3蛋白,捕获了SL RNA RNP复合物和相关的剪接机制,包括催化和核心。在鉴定的25种蛋白中,将验证4种新型的着丝质体特异性蛋白与另外两种剪接同源物的关联和功能。这些目标解决了SL RNA成熟过程中决定其后续功能的离散步骤。特异性抑制反式剪接途径对寄生虫是致命的,因此是临床干预的主要目标。
英文摘要
DESCRIPTION (provided by applicant): Our research is aimed at understanding gene expression in the family Trypanosomatidae, which includes the parasitic protozoa responsible for leishmaniasis, African Sleeping Sickness, and Chagas Disease. The focus is on the genesis and function of the spliced leader (SL) RNA, a small RNA that contributes the 5'-end sequence to every nuclear messenger RNA by a trans-splicing reaction and is conserved extraordinarily at the primary sequence level throughout the Order. Trans-splicing is necessary for the conversion of polycistronic pre-messenger RNA, a likely consequence of the unusual genome organization found in kinetoplastids, into monocistronic mRNA, and is not found in the human host or insect vector, thus representing an ideal therapeutic target. This proposal outlines experiments that detail the maturation pathway of the SL RNA common to Leishmania tarentolae and Trypanosoma brucei at the level of individual proteins and interacting complexes, and probe the role of the SL in translation. 1) We will explore the role of the cap 4 2'-O-ribose methyltransferases in the bloodstream form of T. brucei, and validate their function in procyclic T. brucei using knockout strains. We will investigate the cap-binding properties of TbMTr1, and test models for the role of TbMTAP and TbMTr1 in trafficking and interacting with the pseudouridine synthase complex in the nucleus. 2) To further the characterization of complexes involved in SL RNA biogenesis and function. The trinity of PTP tagging, multidimensional protein identification technology (MudPIT), and the T. brucei genome database enables us to approach complex purification. The kinetoplastid-specific TbMTr1 complex protein TbMTAP is implicated in regulatory and structural interactions. Using the SmD3 protein, the SL RNA RNP complex and associated splicing machinery, both catalytic and core, has been captured. Of the 25 proteins identified, four novel, kinetoplastid-specific proteins will be validated for association and function along with two additional splicing homologs. These goals address discrete steps in the maturation of the SL RNA that determine its subsequent function. Specific inhibition of the trans-splicing pathway is lethal to the parasite and thus a prime target for clinical intervention.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1093/nar/gkr038
发表时间:
2011-06
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Werner M, Purta E, Kaminska KH, Cymerman IA, Campbell DA, Mittra B, Zamudio JR, Sturm NR, Jaworski J, Bujnicki JM]
通讯作者:
Bujnicki JM
DOI:
10.1093/molbev/msp083
发表时间:
2009-08
期刊:
Molecular biology and evolution
影响因子:
10.7
作者:
[Huan Zhang;D. Campbell;N. R. Sturm;Senjie Lin]
通讯作者:
Huan Zhang;D. Campbell;N. R. Sturm;Senjie Lin
DOI:
10.1093/nar/gkj084
发表时间:
2006-01-01
期刊:
NUCLEIC ACIDS RESEARCH
影响因子:
14.9
作者:
[Dunin-Horkawicz, Stanislaw, Czerwoniec, Anna, Gajda, Michal J., Feder, Marcin, Grosjean, Henri, Bujnicki, Janusz M.]
通讯作者:
Bujnicki, Janusz M.
DOI:
10.1371/journal.pgen.1004007
发表时间:
2014-02
期刊:
PLoS genetics
影响因子:
4.5
作者:
[Porcel BM, Denoeud F, Opperdoes F, Noel B, Madoui MA, Hammarton TC, Field MC, Da Silva C, Couloux A, Poulain J, Katinka M, Jabbari K, Aury JM, Campbell DA, Cintron R, Dickens NJ, Docampo R, Sturm NR, Koumandou VL, Fabre S, Flegontov P, Lukeš J, Michaeli S, Mottram JC, Szöőr B, Zilberstein D, Bringaud F, Wincker P, Dollet M]
通讯作者:
Dollet M
Trypanosoma brucei spliced leader RNA maturation by the cap 1 2'-O-ribose methyltransferase and SLA1 H/ACA snoRNA pseudouridine synthase complex.
布氏锥虫通过 cap 1 2-O-核糖甲基转移酶和 SLA1 H/ACA snoRNA 假尿苷合酶复合物剪接前导 RNA 成熟。
DOI:
10.1128/mcb.01496-08
发表时间:
2009
期刊:
Molecular and cellular biology
影响因子:
5.3
作者:
[Zamudio,JesseR, Mittra,Bidyottam, Chattopadhyay,Arnab, Wohlschlegel,JamesA, Sturm,NancyR, Campbell,DavidA]
通讯作者:
Campbell,DavidA
共 11 条
Cap binding and gene expression in trypanosomes
-
批准号:8538532
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2012
-
负责人:DAVID A CAMPBELL
-
依托单位:
Cap binding and gene expression in trypanosomes
-
批准号:8720092
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2012
-
负责人:DAVID A CAMPBELL
-
依托单位:
Cap binding and gene expression in trypanosomes
-
批准号:8152809
-
项目类别:
-
资助金额:$6.89万
-
财政年份:2012
-
负责人:DAVID A CAMPBELL
-
依托单位:
Global sumoylation analysis in Trypanosoma brucei
-
批准号:7825383
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2009
-
负责人:DAVID A CAMPBELL
-
依托单位:
Global sumoylation analysis in Trypanosoma brucei
-
批准号:7659346
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2009
-
负责人:DAVID A CAMPBELL
-
依托单位:
Translational partitioning of the SL RNA
-
批准号:7847643
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2009
-
负责人:DAVID A CAMPBELL
-
依托单位:
Translational partitioning of the SL RNA
-
批准号:7472824
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2009
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:7196546
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:6873642
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA Biogenesis
-
批准号:8284373
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:7024522
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:6777287
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:7386049
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA Biogenesis
-
批准号:7877047
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA Biogenesis
-
批准号:7749899
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA Biogenesis
-
批准号:8091461
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
EXPRESSION OF THE LEISHMANIA TARENTOLAE SL RNA GENE
-
批准号:6510655
-
项目类别:
-
资助金额:$25.49万
-
财政年份:1994
-
负责人:DAVID A CAMPBELL
-
依托单位:
EXPRESSION OF THE LEISHMANIA TARENTOLAE SL RNA GENE
-
批准号:6631930
-
项目类别:
-
资助金额:$26.26万
-
财政年份:1994
-
负责人:DAVID A CAMPBELL
-
依托单位:
EXPRESSION OF THE LEISHMANIA TARENTOLAE SL RNA GENE
-
批准号:6362312
-
项目类别:
-
资助金额:$24.75万
-
财政年份:1994
-
负责人:DAVID A CAMPBELL
-
依托单位:
EXPRESSION OF THE LEISHMANIA TARENTOLAE MINI EXON GENE
-
批准号:2069671
-
项目类别:
-
资助金额:$20.34万
-
财政年份:1994
-
负责人:DAVID A CAMPBELL
-
依托单位:
海外基金